APA (7th ed.) Citation

Chiorean, M. V., Allegretti, J. R., Sharma, P. P., Chastek, B., Salese, L., Bell, E. J., . . . Khan, N. (2022). Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis. BMC Gastroenterology, 22(1), . https://doi.org/10.1186/s12876-022-02215-y

Chicago Style (17th ed.) Citation

Chiorean, Michael V., et al. "Real-world Characteristics, Treatment Experiences and Corticosteroid Utilisation of Patients Treated with Tofacitinib for Moderate to Severe Ulcerative Colitis." BMC Gastroenterology 22, no. 1 (2022). https://doi.org/10.1186/s12876-022-02215-y.

MLA (9th ed.) Citation

Chiorean, Michael V., et al. "Real-world Characteristics, Treatment Experiences and Corticosteroid Utilisation of Patients Treated with Tofacitinib for Moderate to Severe Ulcerative Colitis." BMC Gastroenterology, vol. 22, no. 1, 2022, https://doi.org/10.1186/s12876-022-02215-y.